| Home page | News | About us | Investment | Contact us | 
Position: China Medical City >> News >> Major CMC News >> The text
NAVIGATION
NEWS IN PICTURES

9th China (Taizhou) …

30 Key Medical Proje…

Ada Yonath: The pros…

Thomas c. Sudhof: To…
Aurobindo Pharma Taizhou Project starts construction    Hot     ★★★
Aurobindo Pharma Taizhou Project starts construction

Author:CMC Article source:CMC Click the number:615 Update time:2018-7-30 22:24:51

On the morning of July 20, a project of Aurobindo Pharma Taizhou Co., Ltd. started construction in China Medical City (CMC). With a total investment of USD 100 million, the project has an annual production capacity of 3.5 billion tablets and 500 million capsules, and will generate annual sales of RMB 3 billion after put into production.
    
Aurobindo Pharma Taizhou Co., Ltd. is invested by the headquarters of Aurobindo Pharma Limited in India. Aurobindo Pharma Limited is a large multinational corporation and the second largest listed pharmaceutical company in India with 25 factories or offices spreading over China, the United States, Europe, South America and South Africa. The company operates business in fields such as central nervous system, anti-HIV, angiocarpy, diabetes, gastroenterologicals, and cephalosporins. By the end of 2017, 350 generic drug applications of Aurobindo Pharma had been approved in the United States, exceeding the total number of applications of all Chinese pharmaceutical companies approved there. The company has sold preparations amounting to USD 2.6 billion in the American market, and ranks world first in terms of the sales of APIs, making it a leading manufacturer in the pharmaceutical field.

NewsInputer:CMC    Editor:CMC 
  • Back ArticleNews:

  • Next ArticleNews:
  • 【Typeface:Small Big】【Comment】【Add favorite】【Mail this page】【Print】【Close
      The netizen comments:(Show only the latest 10. Review the content of view, has nothing to do with the stand!)

    | Set home | Add to Favorites | Contact the webmaster | About us |
    Copyright © 2014 Medmax.cn Inc. All rights reserved. Medmax.cn
    The competent units:Taizhou National Medical High-tech Development Zone
    Copyright: Taizhou pharmaceutical hi tech Industrial Park Management Committee
    Tel:0523-86200007;+86-15852977958;0523-86200142;+86-18262307755
    苏ICP备14026810号-1 苏B2-20070164
    回到最上头